Impact of Karnovsky Performance Status (KPS) and activity of temozolomide (TMZ) as first line therapy : retrospective analysis of a cohort of elderly patients (pts) with glioblastoma (GBM)

Authors :: O. Barrié M. Calissi B. Fuentes S. Metellus P. Honoré S. Boucard C. Loundou A. Figarella-Branger D. Dufour H., Chinot
Vidalin, Michèle
Cytosquelette et Intégration des Signaux du Micro-Environnement Tumoral - UMR 6032 (CISMET)
Université de la Méditerranée - Aix-Marseille 2-Université de Provence - Aix-Marseille 1-Centre National de la Recherche Scientifique (CNRS)
Source :: ASCO Annual Meeting (American Society of Clinical Oncology 2006, ASCO Annual Meeting (American Society of Clinical Oncology 2006, 2006, Atlanta, Georgia, June 2-6, United States
Publication Year :: 2006
Publisher :: HAL CCSD, 2006.

Subjects :: [SDV.CAN] Life Sciences [q-bio]/Cancer
[SDV.CAN]Life Sciences [q-bio]/Cancer
[SDV.BC]Life Sciences [q-bio]/Cellular Biology
[SDV.BC] Life Sciences [q-bio]/Cellular Biology

Language :: English
Database :: OpenAIRE
Journal :: ASCO Annual Meeting (American Society of Clinical Oncology 2006, ASCO Annual Meeting (American Society of Clinical Oncology 2006, 2006, Atlanta, Georgia, June 2-6, United States
Accession number :: edsair.dedup.wf.001..15818a6c45bc80cc213fef50abfbe61c

Tools